Pesquisa | Secretaria de Estado da Saúde

1.

Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples.

Khalsa, Jasneet Kaur; Cha, Justin; Utro, Filippo; Naeem, Aishath; Murali, Ishwarya; Kuang, Yanan; Vasquez, Kevin; Li, Liang; Tyekucheva, Svitlana; Fernandes, Stacey M; Veronese, Lauren; Guieze, Romain; Sasi, Binu Kandathilparambil; Wang, Zixu; Machado, John-Hanson; Bai, Harrison; Alasfour, Maryam; Rhrissorrakrai, Kahn; Levovitz, Chaya; Danysh, Brian P; Slowik, Kara; Jacobs, Raquel A; Davids, Matthew S; Paweletz, Cloud P; Leshchiner, Ignaty; Parida, Laxmi; Getz, Gad; Brown, Jennifer R.

Blood ; 142(5): 421-433, 2023 08 03.

Artigo Inglês | MEDLINE | ID: mdl-37146250

2.

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease.

Penter, Livius; Liu, Yang; Wolff, Jacquelyn O; Yang, Lin; Taing, Len; Jhaveri, Aashna; Southard, Jackson; Patel, Manishkumar; Cullen, Nicole M; Pfaff, Kathleen L; Cieri, Nicoletta; Oliveira, Giacomo; Kim-Schulze, Seunghee; Ranasinghe, Srinika; Leonard, Rebecca; Robertson, Taylor; Morgan, Elizabeth A; Chen, Helen X; Song, Minkyung H; Thurin, Magdalena; Li, Shuqiang; Rodig, Scott J; Cibulskis, Carrie; Gabriel, Stacey; Bachireddy, Pavan; Ritz, Jerome; Streicher, Howard; Neuberg, Donna S; Hodi, F Stephen; Davids, Matthew S; Gnjatic, Sacha; Livak, Kenneth J; Altreuter, Jennifer; Michor, Franziska; Soiffer, Robert J; Garcia, Jacqueline S; Wu, Catherine J.

Blood ; 141(15): 1817-1830, 2023 04 13.

Artigo Inglês | MEDLINE | ID: mdl-36706355

3.

Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.

Davids, Matthew S; Rogers, Kerry A; Tyekucheva, Svitlana; Wang, Zixu; Pazienza, Samantha; Renner, Sarah K; Montegaard, Josie; Ihuoma, Udochukwu; Lehmberg, Timothy Z; Parry, Erin M; Wu, Catherine J; Jacobson, Caron A; Fisher, David C; Thompson, Philip A; Brown, Jennifer R.

Blood ; 139(5): 686-689, 2022 02 03.

Artigo Inglês | MEDLINE | ID: mdl-34788401

4.

Hypomethylating agent decitabine sensitizes diffuse large B-cell lymphoma to venetoclax.

Zhu, Fen; Crombie, Jennifer L; Ni, Wei; Hoang, Nguyet-Minh; Garg, Swati; Hackett, Liam; Chong, Stephen J F; Collins, Mary C; Rui, Lixin; Griffin, James; Davids, Matthew S.

Haematologica ; 109(1): 186-199, 2024 Jan 01.

Artigo Inglês | MEDLINE | ID: mdl-37534528

5.

A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.

Merryman, Reid W; Redd, Robert A; Freedman, Arnold S; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Kim, Austin I; LaCasce, Ann S; Ng, Samuel; Odejide, Oreofe O; Parry, Erin M; Isufi, Iris; Kline, Justin; Cohen, Jonathon B; Mehta-Shah, Neha; Bartlett, Nancy L; Mei, Matthew; Kuntz, Thomas M; Wolff, Jacquelyn; Rodig, Scott J; Armand, Philippe; Jacobson, Caron A.

Ann Hematol ; 103(1): 185-198, 2024 Jan.

Artigo Inglês | MEDLINE | ID: mdl-37851072

6.

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer.

Glaviano, Antonino; Foo, Aaron S C; Lam, Hiu Y; Yap, Kenneth C H; Jacot, William; Jones, Robert H; Eng, Huiyan; Nair, Madhumathy G; Makvandi, Pooyan; Geoerger, Birgit; Kulke, Matthew H; Baird, Richard D; Prabhu, Jyothi S; Carbone, Daniela; Pecoraro, Camilla; Teh, Daniel B L; Sethi, Gautam; Cavalieri, Vincenzo; Lin, Kevin H; Javidi-Sharifi, Nathalie R; Toska, Eneda; Davids, Matthew S; Brown, Jennifer R; Diana, Patrizia; Stebbing, Justin; Fruman, David A; Kumar, Alan P.

Mol Cancer ; 22(1): 138, 2023 08 18.

Artigo Inglês | MEDLINE | ID: mdl-37596643

7.

miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.

Sharma, Sonali; Pavlasova, Gabriela Mladonicka; Seda, Vaclav; Cerna, Katerina Amruz; Vojackova, Eva; Filip, Daniel; Ondrisova, Laura; Sandova, Veronika; Kostalova, Lenka; Zeni, Pedro F; Borsky, Marek; Oppelt, Jan; Liskova, Kvetoslava; Kren, Leos; Janikova, Andrea; Pospisilova, Sarka; Fernandes, Stacey M; Shehata, Medhat; Rassenti, Laura Z; Jaeger, Ulrich; Doubek, Michael; Davids, Matthew S; Brown, Jennifer R; Mayer, Jiri; Kipps, Thomas J; Mraz, Marek.

Blood ; 137(18): 2481-2494, 2021 05 06.

Artigo Inglês | MEDLINE | ID: mdl-33171493

8.

BH3 profiling identifies ruxolitinib as a promising partner for venetoclax to treat T-cell prolymphocytic leukemia.

Herbaux, Charles; Kornauth, Christoph; Poulain, Stéphanie; Chong, Stephen J F; Collins, Mary C; Valentin, Rebecca; Hackett, Liam; Tournilhac, Olivier; Lemonnier, François; Dupuis, Jehan; Daniel, Adrien; Tomowiak, Cecile; Laribi, Kamel; Renaud, Loïc; Roos-Weil, Damien; Rossi, Cedric; Van Den Neste, Eric; Leyronnas, Cecile; Merabet, Fatiha; Malfuson, Jean Valère; Tiab, Mourad; Ysebaert, Loïc; Ng, Samuel; Morschhauser, Franck; Staber, Philipp B; Davids, Matthew S.

Blood ; 137(25): 3495-3506, 2021 06 24.

Artigo Inglês | MEDLINE | ID: mdl-33598678

9.

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation.

Penter, Livius; Zhang, Yi; Savell, Alexandra; Huang, Teddy; Cieri, Nicoletta; Thrash, Emily M; Kim-Schulze, Seunghee; Jhaveri, Aashna; Fu, Jingxin; Ranasinghe, Srinika; Li, Shuqiang; Zhang, Wandi; Hathaway, Emma S; Nazzaro, Matthew; Kim, Haesook T; Chen, Helen; Thurin, Magdalena; Rodig, Scott J; Severgnini, Mariano; Cibulskis, Carrie; Gabriel, Stacey; Livak, Kenneth J; Cutler, Corey; Antin, Joseph H; Nikiforow, Sarah; Koreth, John; Ho, Vincent T; Armand, Philippe; Ritz, Jerome; Streicher, Howard; Neuberg, Donna; Hodi, F Stephen; Gnjatic, Sacha; Soiffer, Robert J; Liu, X Shirley; Davids, Matthew S; Bachireddy, Pavan; Wu, Catherine J.

Blood ; 137(23): 3212-3217, 2021 06 10.

Artigo Inglês | MEDLINE | ID: mdl-33720354

10.

Pirtobrutinib versus venetoclax in covalent Bruton tyrosine kinase inhibitor-pretreated chronic lymphocytic leukemia: a matching-adjusted indirect comparison.

Al-Sawaf, Othman; Jen, Min-Hua; Hess, Lisa M; Zhang, Jiewen; Goebel, Benjamin; Pagel, John M; Abhyankar, Sarang; Davids, Matthew S; Eyre, Toby A.

Haematologica ; 2023 Nov 30.

Artigo Inglês | MEDLINE | ID: mdl-38031799

11.

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.

Mato, Anthony R; Shah, Nirav N; Jurczak, Wojciech; Cheah, Chan Y; Pagel, John M; Woyach, Jennifer A; Fakhri, Bita; Eyre, Toby A; Lamanna, Nicole; Patel, Manish R; Alencar, Alvaro; Lech-Maranda, Ewa; Wierda, William G; Coombs, Catherine C; Gerson, James N; Ghia, Paolo; Le Gouill, Steven; Lewis, David John; Sundaram, Suchitra; Cohen, Jonathon B; Flinn, Ian W; Tam, Constantine S; Barve, Minal A; Kuss, Bryone; Taylor, Justin; Abdel-Wahab, Omar; Schuster, Stephen J; Palomba, M Lia; Lewis, Katharine L; Roeker, Lindsey E; Davids, Matthew S; Tan, Xuan Ni; Fenske, Timothy S; Wallin, Johan; Tsai, Donald E; Ku, Nora C; Zhu, Edward; Chen, Jessica; Yin, Ming; Nair, Binoj; Ebata, Kevin; Marella, Narasimha; Brown, Jennifer R; Wang, Michael.

Lancet ; 397(10277): 892-901, 2021 03 06.

Artigo Inglês | MEDLINE | ID: mdl-33676628

12.

A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation.

Davids, Matthew S; Kim, Haesook T; Costello, Caitlin; Herrera, Alex F; Locke, Frederick L; Maegawa, Rodrigo O; Savell, Alexandra; Mazzeo, Michael; Anderson, Adrienne; Boardman, Alexander P; Weber, Augustine; Avigan, David; Chen, Yi-Bin; Nikiforow, Sarah; Ho, Vincent T; Cutler, Corey; Alyea, Edwin P; Bachireddy, Pavan; Wu, Catherine J; Ritz, Jerome; Streicher, Howard; Ball, Edward D; Bashey, Asad; Soiffer, Robert J; Armand, Philippe.

Blood ; 135(24): 2182-2191, 2020 06 11.

Artigo Inglês | MEDLINE | ID: mdl-32478814

13.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience.

Mato, Anthony R; Roeker, Lindsey E; Lamanna, Nicole; Allan, John N; Leslie, Lori; Pagel, John M; Patel, Krish; Osterborg, Anders; Wojenski, Daniel; Kamdar, Manali; Huntington, Scott F; Davids, Matthew S; Brown, Jennifer R; Antic, Darko; Jacobs, Ryan; Ahn, Inhye E; Pu, Jeffrey; Isaac, Krista M; Barr, Paul M; Ujjani, Chaitra S; Geyer, Mark B; Berman, Ellin; Zelenetz, Andrew D; Malakhov, Nikita; Furman, Richard R; Koropsak, Michael; Bailey, Neil; Hanson, Lotta; Perini, Guilherme F; Ma, Shuo; Ryan, Christine E; Wiestner, Adrian; Portell, Craig A; Shadman, Mazyar; Chong, Elise A; Brander, Danielle M; Sundaram, Suchitra; Seddon, Amanda N; Seymour, Erlene; Patel, Meera; Martinez-Calle, Nicolas; Munir, Talha; Walewska, Renata; Broom, Angus; Walter, Harriet; El-Sharkawi, Dima; Parry, Helen; Wilson, Matthew R; Patten, Piers E M; Hernández-Rivas, José-Ángel.

Blood ; 136(10): 1134-1143, 2020 09 03.

Artigo Inglês | MEDLINE | ID: mdl-32688395

14.

MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma.

Ryan, Christine E; Davids, Matthew S; Hermann, Richard; Shahkarami, Mina; Biondo, Juliana; Abhyankar, Sarang; Alhasani, Hasan; Sharman, Jeff P; Mato, Anthony R; Roeker, Lindsey E.

Future Oncol ; 18(33): 3689-3699, 2022 Oct.

Artigo Inglês | MEDLINE | ID: mdl-36102212

15.

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study.

Davids, Matthew S; Lampson, Benjamin L; Tyekucheva, Svitlana; Wang, Zixu; Lowney, Jessica C; Pazienza, Samantha; Montegaard, Josie; Patterson, Victoria; Weinstock, Matthew; Crombie, Jennifer L; Ng, Samuel Y; Kim, Austin I; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Arnason, Jon E; Fisher, David C; Brown, Jennifer R.

Lancet Oncol ; 22(10): 1391-1402, 2021 10.

Artigo Inglês | MEDLINE | ID: mdl-34534514

16.

Small molecules, big impact: 20 years of targeted therapy in oncology.

Bedard, Philippe L; Hyman, David M; Davids, Matthew S; Siu, Lillian L.

Lancet ; 395(10229): 1078-1088, 2020 03 28.

Artigo Inglês | MEDLINE | ID: mdl-32222192

17.

Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables.

Roberts, Andrew W; Ma, Shuo; Kipps, Thomas J; Coutre, Steven E; Davids, Matthew S; Eichhorst, Barbara; Hallek, Michael; Byrd, John C; Humphrey, Kathryn; Zhou, Lang; Chyla, Brenda; Nielsen, Jacqueline; Potluri, Jalaja; Kim, Su Young; Verdugo, Maria; Stilgenbauer, Stephan; Wierda, William G; Seymour, John F.

Blood ; 134(2): 111-122, 2019 07 11.

Artigo Inglês | MEDLINE | ID: mdl-31023700

18.

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Staber, Philipp B; Herling, Marco; Bellido, Mar; Jacobsen, Eric D; Davids, Matthew S; Kadia, Tapan Mahendra; Shustov, Andrei; Tournilhac, Olivier; Bachy, Emmanuel; Zaja, Francesco; Porkka, Kimmo; Hoermann, Gregor; Simonitsch-Klupp, Ingrid; Haferlach, Claudia; Kubicek, Stefan; Mayerhoefer, Marius E; Hopfinger, Georg; Jaeger, Ulrich; Dearden, Claire.

Blood ; 134(14): 1132-1143, 2019 10 03.

Artigo Inglês | MEDLINE | ID: mdl-31292114

19.

Functional cure reported in CLL.

Davids, Matthew S.

Blood ; 142(21): 1761-1763, 2023 11 23.

Artigo Inglês | MEDLINE | ID: mdl-37995104

20.

The rise of apoptosis: targeting apoptosis in hematologic malignancies.

Valentin, Rebecca; Grabow, Stephanie; Davids, Matthew S.

Blood ; 132(12): 1248-1264, 2018 09 20.

Artigo Inglês | MEDLINE | ID: mdl-30012635

Secretaria de Estado da Saúde - BVS

Rede de Informação e Conhecimento

Sua seleção (0)

Formato de exportação:

Exportar: